Low‐risk HLA genotype in Type 1 diabetes is associated with less destruction of pancreatic B‐cells 12 months after diagnosis
- 26 November 2007
- journal article
- Published by Wiley in Diabetic Medicine
- Vol. 24 (12) , 1487-1490
Abstract
Aims The role of human leukocyte antigen (HLA) genes in the susceptibility to Type 1 diabetes (T1DM) is well known. However, we do not know whether the degree of pancreatic B‐cell destruction depends on different HLA genetic risk. The aim of this study was to analyse the influence of DRB1* and DQB1* genes on the rate of pancreatic B‐cell loss in a prospective series of 120 consecutive newly diagnosed T1DM subjects in the first 12 months after diagnosis. Methods Patients were typed for HLA‐DRB1* and DQB1* loci by a reverse line blot assay using an array of immobilized sequence‐specific oligonucleotide probes. C‐peptide, insulin requirement and glycated haemoglobin (HbA1c) were determined at diagnosis and every 3 months for 12 months. The variance of C‐peptide as evidence of B‐cell loss during follow‐up was analysed using the general linear model for repeated‐measures procedure. Results Fasting C‐peptide in T1DM subjects with low HLA genetic risk was significantly higher when compared with subjects with moderate or high HLA genetic risk from time of diagnosis up to 12 months (P = 0.007 and P = 0.0002, respectively). Nonetheless, the changes in C‐peptide levels over a 12‐month period did not differ significantly between T1DM subjects with different HLA genetic risks. Conclusions Low‐risk HLA genotype in T1DM is associated with less destruction of pancreatic B‐cells up to 12 months after diagnosis. These results are useful when designing trials for therapies aimed to prevent the progression of B‐cell destruction in recent‐onset T1DM.Keywords
This publication has 23 references indexed in Scilit:
- Residual insulin secretion at diagnosis of type 1 diabetes is independently associated with both, age of onset and HLA genotypeDiabetes/Metabolism Research and Reviews, 2005
- Genetic prediction of type 1 diabetes in a population with low frequency of HLA risk genotypes and low incidence of the disease (the DIABFIN study)Diabetes/Metabolism Research and Reviews, 2004
- A linkage study of 12 IDDM susceptibility loci in the Finnish populationDiabetes/Metabolism Research and Reviews, 2004
- Islet antibodies and remaining β‐cell function 8 years after diagnosis of diabetes in young adults: a prospective follow‐up of the nationwide Diabetes Incidence Study in SwedenJournal of Internal Medicine, 2004
- Environmental risk factors for type 1 diabetes in Rome and provinceArchives of Disease in Childhood, 2003
- Metabolic and immune parameters at clinical onset of insulin-dependent diabetes: A population-based studyMetabolism, 1998
- Effect of genetic risk load defined by HLA‐DQB1 polymorphism on clinical characteristics of ID DM in childrenEuropean Journal of Clinical Investigation, 1995
- Early environmental events as a cause of IDDM. Evidence and implicationsDiabetes, 1994
- Association of HLA-A24 with complete beta-cell destruction in IDDMDiabetes, 1993
- Relationships among islet cell antibodies, residual β-cell function, and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: Use of a sensitive C-peptide radioimmunoassayMetabolism, 1990